Amoul Portfolio

Quick Update:

Added more of Gravita India. Planning to make it a core part of my portfolio.

Stock Profit % Protfolio %
Zomato 138% 16%
NTSP 150% 30%
Angel One -11% 13%
DP Abhushan 101% 10%
LT Foods 49% 10%
TPCL Packaging 25% 7%
Bajaj Finance -9% 9%
Gravita India 14% 6%

Other Stocks on my Radar

  • Dr Agarwal eye hospital
  • Trust Fintech
  • BLS International

I don’t want more than 8 stocks in my portfolio, might churn based on potential.

Hi Amoul, are you planning to change your allocation in NPST, given its trading at very high P/E of 125?

1 Like

Dont plan to change anything at the moment.

I still think there is a lot of upside left. Company is growing at more than 100% YoY and forward-looking PE still looks good.

Also, I have learnt that in the bull run you should ride on your winner. In bull market focus on valuation reduces and growth increases. If there is a broader change in market sentiment I will think about this.

NPST Ltd, with its focus on fintech and banking tech solutions, is well-positioned for the booming digital payments sector. Rapid 100% growth and experienced promoters are strong positives. A PE of 114 is high but may be justified by robust growth potential and market demand.

PORTFOLIO UPDATE:

Stock Profit % Protfolio %
Zomato 151% 15%
NTSP 110% 22%
Angel One 12% 14%
DP Abhushan 175% 12%
Dr Agarwal 29% 14%
TPCL Packaging 44% 7%
Bajaj Finance 3% 9%
Gravita India 43% 6%

Sold entire Holding of LT Foods:

  • PE reached an all-time high for LT foods and there is less scope for valuation expansion, The Company will still grow at a healthy rate but returns might be limited to profit growth and not PE expansion. Also I found a better opportunity in Dr Agarwal Eye Hospital.

Added Dr Agarwal Eye Hospital

  • Dr Agarwal is a core part of my portfolio now (more than 10% allocation)
  • Eye care industry is going through a transformation of shifting from an unorganised to an organized sector, this can benefit the company
  • Showing a strong profit growth of 31% in last 5 years and OPM is also increasing YoY which means the company is getting more efficient
  • The company is planning to open more hospitals that will drive growth along with an increase in services offered through the same store

NPST Update

  • NPST has fallen by more than 30% from its top. There have been concerns about the drop in future profit but I am waiting for its quarterly results post will make a decision if it is a good time to increase the allocation

Other Stocks on Radar

  • BLS International
  • Yatharth Hospitals
  • Manan In Store
1 Like

PORTFOLIO UPDATE:

Stock Profit % Protfolio %
Zomato 136% 13%
NPST 137% 23%
Angel One 22% 14%
DP Abhushan 134% 10%
Dr Agarwal 29% 17%
TCPL Packaging 29% 5%
BLS International 33% 10%
Gravita India 23% 8%

Sold Bajaj Finance

  • I think this is still a good buy at the current valuation, Dont know how much one will have to wait but this will give good returns.
  • Sold as I found a better opportunity elsewhere.

Added more of Dr Agarwal

  • I see a lot of potential in the eye care industry for the reasons mentioned above. Bought more of this.

Added more of Gravita

  • Gravita fell approximately 20% from the top in Oct. Used that opportunity to buy more.

Loaded BLS International

  • BLS is the only listed player in India in the visa and consular space, it is a competitor of VFS.
  • Core business model has a lot of entry to barriers and BLS at present holds 15-16% of the world’s VISA Processing. Its a good way to play the growth of global tourism.
  • Stock has an RoE of around 31% and has grown at more than 50% in the last 3 years.
  • Management is migrating the business from partner-run to self-run centers which should improve the margins
  • 50% growth stock available at PE of 45 looks like a good buy.
  • On the negative side BLS has done a lot of acquisition recently and the question of right capital allotment remains to be answered.

Other Stocks on Radar

  • IDFC Bank
  • Creditaccess Gramin: I was trying to find a thread of this in VP but could not
  • Chatha Foods

Here is the link for credit access grameen CreditAccess Grameen: Traditional MFI model, efficiently operating at scale

1 Like

PORTFOLIO UPDATE:

  • A lot has happened in the market in the last 3 months and my portfolio has also gone through major changes.
  • Most of my gains have eroded in the fall but stocks seem to have found their bottom (only time will tell). At this point increased the number of stocks in the portfolio to be safe.
  • Added more of TCPL as the results were very good and I expect a consumer boom in coming years which should benefit TCPL Packaging
  • I also added small quantities of Dr Agarwal and BLS International.
Stock Profit % Protfolio %
Dr Agarwal -9% 17%
Zomato 98% 16%
Angel One -6% 15%
TCPL Packaging 59% 12%
BLS International -2% 11%
Gravita India -4% 9%
CDSL -17% 7%
KPIT Tech 0% 4%
Ksolves 0% 4%

Sold Entire holding of NPST (profit of 33%)

  • While I still believe in the long-term story of NPST and plan to enter this stock again sold it for now as the company is facing issues with its baking partners which led to a decline in revenue and profit for Q4 2024 and being a high PE stock the scope of downside is still here.
  • I plan to wait for next quarter’s results before entering again unless there is another 20-25% fall from here which will give a good point of entry.

Sold Entire holding on DP Abhushan (profit of 153%)

  • Attended the concall for the first time and came to know that the company does not have a view on how to hedge itself against the gold price changes. Since gold prices are on the rise as of now company is benefitting from this but if it starts to decline this will impact the margins of the company.
  • As the gold prices are still on the rise company will do well but I don’t want to count on the rising gold prices and hence exited.

Entered KPIT Tech

  • Don’t think I have to comment on the business model and revenue growth opportunities. This stock is well known in the market.
  • KPIT Tech is down more than 30% from its top and its PE is less than its 5-year average of 52, market cap to sales has also corrected a lot. Felt like a good bet with less downside.
  • This felt like a good point to buy, stock may still be down from here but looks good for 2-3 year horizon.

Entered CDSL

  • I believe India’s capital market is going to explode in the next 5 years and I am trying to find good opportunities here.
  • CDSL is a duopoly business and its growth will be directly proportional to capital market growth.
  • Stock has corrected more than 35% from its top and is at average PE and Mcap/sales of last 5 years.
  • If the market does not recover from there CDSL might go down or go sideways for a long time before going up.

Entered Ksolves

  • Has shown profit and revenue growth of more than 60% in the last 3 years. It’s available at a PE of 27 which is much less than its historical average and less for a smallcap IT company.
  • Its OPM has decreased over the last 5 years and that might be the reason why stock is down almost 40% from its top.
  • IT as an industry has gone sideways for the last couple of years and it’s picking up again so smallcap IT should benefit from this.
  • Management is positive of growing at more than 30% while maintaining 35% ROCE.

Other stocks on Radar

  • Bikaji Foods
  • Vadilal Industries

Would really appreciate thoughts and comments on the profolio.

2 Likes

PORTFOLIO UPDATE:

  • Made some changes based on the recent tariff news and changes in macro

Sold KPIT (at a loss of 24%)

  • While I still feel this stock can perform well, recent tariff news and slowdown in the automobile industry can impact the business

Bought Ujjivan Small Finance Bank

  • I feel banks and NBFCs have found their bottom, and they have already started going up
  • There have been 2 rate cuts by the RBI, and liquidity should flow into the market. Banks will benefit from this
  • Bought at P/B ratio of 1.2, where I felt not a lot of downside left. I also feel NPA issues with SMB have mostly been sorted, and the books are clean now.

Bought Cantabil Retail

  • EBIDT growth of 30%+ for the last 3 years and available at a PE of 30 which I think is quite lucrative.
  • Counting on Tier 2 growth, as tax benefit reaches middle income groups which is the TG for Cantabil retail growth should follow
  • Unique business model where they manufacture and sell through their own store, giving them the benefit of higher profit margins

Bought Chatha Foods

  • Chatha Foods in the frozen, ready-to-eat poultry and meat manufacturing
  • I love the management transparency; they even publish the recordings of investor meetings, which is very rare. Give me a huge boost in confidence, which is critical for the SME space
  • Frozen food market is bound to grow and GDP Per Capita increases, the demand will come from both restaurants as well as retail. Right now, Chatha Foods is in the B2B business but has the potential to enter retail as well.
  • Doing a lot of capex to increase the capacity, the management targets a 5x to 6x growth in PAT by FY '28, even if they achieve half of it stock should do well.
  • Potential for both PE expansion as well as PAT growth.

Apart from this added more of Ksolves

Stock Profit % Protfolio %
Angel One 7% 18%
Dr Agarwal -1% 16%
Zomato 85% 11%
BLS International 8% 10%
TCPL Packaging 51% 9%
Chatha Foods -1% 8%
Gravita India 23% 7%
CDSL 6% 7%
Ksolves 3% 5%
Ujjivan Small Finance Bank 24% 5%
Cantabil Retail 2% 3%
4 Likes

Portfolio Update

Angel One:

  • Finally, the patience is paying off. Angel One is up 60% from its bottom. Angel One has the highest allocation in my portfolio. I expect some cool down from here.

Ather:

  • Picked up significant shares during the IPO.
  • I have personally been using Ather and am a big advocate of the product and management. This might take some time to show results, but it should pick up.
  • Ather is trading at 11k CR, which roughly comes out to be 1.5 billion dollars. Ather available at 1.5 Bn$ valuation sounds like a great deal to me.

Other Updates:

  • Bought a little bit more of Ujjian, Ksolves and Cantabil retail.
  • There are 12 stocks in my portfolio. I don’t want to add more, I am looking to exit from 1-2. Any suggestions would be helpful.
  • Overall portfolio is sitting at 19% gain
Stock Profit % Protfolio %
Angel One 41% 19%
Dr Agarwal -1% 13%
Zomato 122% 11%
BLS International 10% 8%
CDSL 41% 8%
Ather -4% 7%
TCPL Packaging 47% 7%
Chatha Foods -7% 7%
Gravita India 15% 6%
Ujjivan Small Finance Bank 19% 5%
Ksolves -21% 4%
Cantabil Retail 3% 4%

Other stocks I am tracking

  • Sky Gold
  • NPST: Will enter this as soon as valuation looks attractive
2 Likes

Portfolio Update

Ather

  • Added more of ather post IPO and looks like its paying off.
  • June quarter results were quite good they have reduced the expenses and losses has trimmed down significantly
  • Growing market share in rest of the India (expect south) as well

Zomato

  • Sold around 30% of my zomato portfolio
  • Still see a lot of growth here but valuations looks stretched.
  • I also feel food delivery and grocery delivery might go through a rough patch as a lot of new players are coming
  • Still bulling on zomato mainly because of its founders.

BLS International

  • While the company is giving amazing results it is still going through a consolidation phase
  • Looks cheap at this point if the stock does not move for another quarter and company gives similar growth will add more.

NPST

  • Added NPST a little, company has passed the rough phase and getting back on gorwth
  • Management is positive about reaching highest profit numbers by Dec quarter. If the results are good or stock goes down will add more.
Stock Profit % Protfolio %
Angel One 18% 16%
Dr Agarwal 3% 14%
Ather 30% 13%
Zomato 133% 9%
BLS International -1% 7%
CDSL 28% 7%
Chatha Foods -10% 6%
TCPL Packaging 34% 6%
Gravita India 8% 5%
Ujjivan Small Finance Bank 17% 5%
NPST 0% 4%
Ksolves -26% 4%
Cantabil Retail 4% 4%

Any inputs is really appreciated

4 Likes

Portfolio Update:

Dr Agarwal

  • Sold Dr Agarwal after clarification on the merger by management. The companies plan to merge their operations by 2027. I was really confused here, this is my first time with a stock from my portfolio ig going through a merger. I am not sure how to evaluate the future prospects, and hence sold.
  • Got a small gain of 10%

Angel One

  • Really frustrated with the price action of Angel One. Every day, new news emerges regarding the FnO ban/restrictions, which prevent the stock from moving.
  • Not planning to sell at the moment, but if the stock corrects another 20% will add more
  • Listing of Groww (at 8Bn$) might trigger the movement again.

NPST

  • Added a little bit more of NPST
  • Management is confident of achieving its highest revenue and profit by Q4 2025. If they can do that, there’s a lot of upside here.
  • The solutions they are building are cutting-edge, and with increased UPI penetration, they are going to do well.

Travel Food Services Lt

  • Added Travel Food Services Ltd, they are into operating lounges and restaurants at airports
  • Betting on the growth of domestic travel and an increase in discretionary spending
  • One concern is what happened with Dreamfolks, wondering if Travel Food Services can also be cornered by some big company in the future

Also thinking of reducing exposure of tracking portfolio (portfolio % less than 5%) to less than 15% overall. Right now its too much diversification.
Bought a tracking position in Urban Company as well.

Stock Profit % Protfolio %
Ather 68% 18%
Angel One -7% 13%
Zomato 131% 10%
BLS International -10% 8%
NPST 0% 7%
CDSL 19% 7%
TCPL Packaging 27% 6%
Chatha Foods -17% 6%
Travel Food Services Lt 5% 5%
Ujjivan Small Finance Bank 17% 5%
Gravita India -2% 5%
Ksolves -26% 4%
Cantabil Retail 4% 4%
Urban Company 6% 1%

Any thoughts or feedback is appreciated.

2 Likes

Did some major changes in the portfolio.

BLS International

  • Exited my position in BLS International at a 26% loss following the MEA order controversy. While the High Court has since ruled in BLS’s favor and the stock has recovered, I chose to exit due to lingering corporate governance concerns.
  • I still believe in the business model and its potential, but I prefer not to hold investments that cause me undue worry. As the saying goes, no investment is worth losing sleep over.

Gold and Silver

  • Made a significant allocation to silver approximately 2.5 months ago, deploying nearly all available cash. This position has delivered good returns so far.
  • My investment thesis is straightforward: industrial demand for silver will continue growing over the next 5 years while supply remains constrained, creating a favourable supply-demand imbalance.
  • My target price range is $90-100/oz. While this isn’t backed by detailed fundamental analysis, I believe silver supply will remain tight for the foreseeable future, which should support higher prices.
  • Also initiated a smaller position in gold as a long-term hedge, anticipating USD weakness due to current macro policies.

PNGS Gargi Fashion

  • Established a tracking position in PNGS Gargi Fashion.
  • The company is delivering impressive metrics: 100%+ bottom-line growth while maintaining ~45% ROE. Currently trading at a PE of just 3.6, which appears attractive.
  • Small market cap of ₹1,000 Cr with strong demand fundamentals.

Urban Company, NPST, CDSL

  • Initiated small positions in all three names.
  • CDSL is my long-term conviction play—I plan to accumulate more on any corrections.
  • Watching Urban Company closely and will add once it establishes a clear base.
  • Added to NPST during its recent correction. I maintain my view that NPST can grow 50%+ annually over the next 3-5 years.
Stock Profit % Protfolio %
HDFC Silver ETF 49% 25%
Ather 131% 17%
Angel One 3% 10%
Zomato 98% 6%
GOLDETF 1% 5%
NPST -28% 5%
CDSL 23% 5%
Travel Food Services Lt -10% 4%
Ujjivan Small Finance Bank 37% 4%
Gravita India 16% 4%
TCPL Packaging 15% 4%
PNGS Gargi Fashion -11% 4%
Cantabil Retail 10% 3%
Ksolves -33% 3%
Urban Company -9% 2%

Any thoughts or feedback are appreciated.

3 Likes